moxifloxacin has been researched along with gs 4071 in 3 studies
Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (gs 4071) | Trials (gs 4071) | Recent Studies (post-2010) (gs 4071) |
---|---|---|---|---|---|
3,157 | 552 | 1,690 | 190 | 16 | 140 |
Protein | Taxonomy | moxifloxacin (IC50) | gs 4071 (IC50) |
---|---|---|---|
Neuraminidase | Influenza A virus (A/Turkey/651242/2006(H5N1)) | 1.4208 | |
Neuraminidase | Influenza A virus (A/Wilson-Smith/1933(H1N1)) | 0.4952 | |
Neuraminidase | Influenza A virus (A/duck/Laos/25/2006(H5N1)) | 1.63 | |
Neuraminidase | Influenza A virus (A/Puerto Rico/8/1934(H1N1)) | 0.0175 | |
Neuraminidase | Influenza A virus (A/USSR/90/1977(H1N1)) | 0.0079 | |
Neuraminidase | Influenza A virus (A/Wilson-Smith/1933(H1N1)) | 0.1851 | |
Neuraminidase | Influenza A virus (A/Memphis/1/1971(H3N2)) | 0.0039 | |
Neuraminidase | Influenza B virus (B/Lee/1940) | 0.0085 | |
Neuraminidase | Influenza A virus (A/udorn/1972(H3N2)) | 0.5813 | |
Sialidase | Clostridium perfringens | 0.001 | |
Substance-P receptor | Cavia porcellus (domestic guinea pig) | 0.015 | |
Histamine H1 receptor | Cavia porcellus (domestic guinea pig) | 2.8247 | |
D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0089 | |
Neuraminidase | Influenza A virus (A/duck/Ukraine/1/1963(H3N8)) | 0.0089 | |
Neuraminidase | Influenza A virus (A/udorn/1972(H3N2)) | 0.0029 | |
Substance-K receptor | Cavia porcellus (domestic guinea pig) | 0.015 | |
Neuraminidase | Influenza A virus (A/swine/Hong Kong/127/1982(H3N2)) | 0.17 | |
Neuraminidase | Influenza A virus (A/Thailand/1(KAN-1)/2004(H5N1)) | 0.0007 | |
Neuraminidase | Influenza A virus (A/budgerigar/Hokkaido/1/1977(H4N6)) | 0.0153 | |
Integrase | Human immunodeficiency virus 1 | 1.785 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
3 other study(ies) available for moxifloxacin and gs 4071
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |